���ϸ�����

News from ���ϸ����� Langone Health

A 13-Year-Old Had Chest Pains. A Rare Disease Meant He Was “Close To Sudden Cardiac Death.” (CBS News)

(7/12) Rakesh Singh, MD, the Haugland Family Associate Professor of Pediatric Cardiology, Department of Pediatrics, Hassenfeld Children’s Hospital, explained that Danon disease, caused by mutations in the LAMP2 gene, leads to heart failure unresponsive to medication, often necessitating heart transplants by the patients’ 20s; Brittany and Micah Clayborne, diagnosed with this rare disease, underwent heart transplants, and have since launched Transplant Teenz, a virtual support community for teenagers awaiting organ transplants, to address the lack of resources for teens in similar situations.

NJ Woman Hospitalized “One Step Before Liver Failure” After Taking Popular Supplement. (New York Post)

(7/11) A New Jersey woman was treated at ���ϸ����� Langone Health for severe liver damage caused by excessive turmeric supplement intake, with Nikolaos Pyrsopoulos, MD, MBA, PhD, clinical professor, Department of Medicine, Division of Gastroenterology and Hepatology, Transplant Institute, saying, “It was very serious,” adding, “Katie actually was one step before full liver damage, liver failure, requiring liver transplant.”

Also reporting are (7/11) and (7/13).

What Is VO2 Max? The Metric That Could Give You Better Workouts. (USA Today)

(7/13) Heather A. Milton, MS, RCEP, CSCS, exercise physiologist supervisor, Sports Performance Center, explained that VO2 max measures the maximum amount of oxygen your body uses during exercise, which is crucial for producing energy through adenosine triphosphate (ATP) in muscles; improving this metric can enhance endurance and cardiovascular health, with methods like high intensity interval training (HIIT) and consistent aerobic exercise being effective ways to increase VO2 max, although its necessity varies depending on individual exercise goals.

Black Adults Lose Less Body Weight After Sleeve Gastrectomy Than White, Hispanic Adults. (Healio)

(7/11) A study published in Obesity found that Black adults experienced lower total weight loss and higher HbA1c levels two years after sleeve gastrectomy compared to white and Hispanic adults, with Sally M. Vanegas, PhD, research assistant professor, Department of Medicine, suggesting the need for more personalized care due to racial and ethnic disparities affecting outcomes. Melanie R. Jay, MD, professor, Department of Medicine, Division of General Internal Medicine and Clinical Innovation, and Department of Population Health, emphasized the effectiveness of bariatric surgery for weight loss across all groups, advocating for increased access and support, while also calling for further research to understand disparities and the impact of environmental and behavioral factors on different populations.

Navigate Successful Cataract Surgery With Refractive Technology. (Opthalmology Times)

(7/11) Advancements in surgical technology have blurred the lines between cataract and refractive surgeries, with newer technologies optimizing uncorrected vision post-cataract surgery, said Christina R. Prescott, MD, PhD, chair, Division of Cornea Services, vice chair, Education, and associate professor, Department of Ophthalmology, sharing insights on managing patient expectations and preoperative steps for cataract surgery post-refractive procedures, emphasizing the importance of managing dry eye, considering visual field defects, and using technology for precise measurements and lens choices, while cautioning about potential challenges in IOL calculations and the need for postsurgical management, reassurance, and a plan for refractive surprises.

Five Under 5: Top Oncology Videos For The Week Of 7/6. (OncLive)

(7/13) Janice Mehnert, MD, professor, Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter Cancer Center, presented findings at the 2025 ASCO Annual Meeting from a phase 2 trial (NCT05428007) assessing the combination of sarilumab (Kevzara), ipilimumab (Yervoy), nivolumab (Opdivo), and relatlimab in patients with unresectable stage III or IV melanoma, reporting a 24-week overall response rate of 63.6% and a clinical benefit rate of 78.8%, with grade 3/4 immune-related adverse events in 12.1% of patients, suggesting sarilumab may reduce toxicity without affecting efficacy.

HIMSS AI Forum: Implementing Agentic AI In Healthcare Requires Caution. (MobiHealthNews)

(7/11) At the HIMSS AI Forum, Jonah Feldman, MD, assistant professor, Department of Medicine, Division of General Internal Medicine and Innovation, discussed the cautious integration of agentic AI in healthcare, particularly in diagnostic workflows, emphasizing the responsibility physicians bear in patient decision-making despite AI assistance.

Brain RNA Influences Change-Of-Mind Behavior In Females. (Technology Networks)

(7/14) A study led by the Icahn School of Medicine at Mount Sinai, with contributions from ���ϸ����� Grossman School of Medicine, has identified a traditionally overlooked type of RNA, LINC00473, as crucial in promoting resilience to depression in females by affecting decision-making processes in the brain, specifically in the prefrontal cortex, with implications for developing new treatments targeting depressive symptoms related to negative rumination; Orna Issler, PhD, assistant professor, Departments of Neuroscience, and Anesthesiology, Perioperative Care, and Pain Medicine, co-author of the study, said, “We translated these findings into an animal laboratory model and demonstrated a causal role of prefrontal LINC00473, when experimentally increased, in promoting resilience to stress in female mice only.”

Modern HIV Rapid Test Similar To COVID Rapid Test. (Managed Healthcare Executive)

(7/11) Anna Bershteyn, PhD, associate professor, Department of Population Health, discussed the affordability and simplicity of the “A-0” HIV antibody blood test, available for approximately 70 cents in many low- and middle-income countries, which resembles a COVID test strip with control and result bands; further testing is generally needed to confirm initial positive results, and Bershteyn will present related research on HIV self-testing and PrEP program monitoring at the International AIDS Society Conference on HIV Science in Kigali, Rwanda.

Heart-Disease Deaths Worldwide Linked To Common Plastic Chemical. (Pharmatutor)

(7/11) A comprehensive global analysis by ���ϸ����� Langone Health has found a startling association between daily exposure to the plastic additive di-2-ethylhexyl phthalate (DEHP) and hundreds of thousands of heart-related deaths, with the study estimating that in 2018, DEHP exposure contributed to 356,238 heart disease deaths worldwide, accounting for over 13 percent of cardiac deaths among adults aged 55–64; the research, published in Lancet eBioMedicine, emphasizes the need for global regulations, particularly in regions like South Asia and the Middle East, where industrial growth and weaker regulations exacerbate the issue, and suggests the potential for reducing DEHP exposure to lower mortality rates, as well as exploring impacts on preterm birth and endocrine systems.

Can AI Assisted Technique Measure And Track Aging Cells? (Only my health)

(7/12) Researchers at ���ϸ����� Grossman School of Medicine have utilized high-resolution imaging and machine learning to track senescent cells, which are crucial in understanding tissue regeneration, aging, and diseases like cancer and heart disease; the study, published in Nature, reveals that nuclear morphometrics can identify these cells, with senior investigator Michael N. Wosczyna, PhD, assistant professor, Department of Orthopedic Surgery, stating, “Our testing platform provides a robust platform to study senescent cells more readily than has been possible before, and to evaluate potential treatments, such as senolytics, that target senescent cells in different tissues and pathologies.”

Parents Crashing Honeymoons Becomes Bizarre New Travel Trend. (New York Post)

The (7/11) Thea Gallagher, PsyD, clinical associate professor, Department of Psychiatry, discussed the emerging trend of bringing family on honeymoons with Fox News Digital, describing it as an “interesting concept” that depends on one’s relationship with their parents and agreement with their partner, stressing the importance of pre-establishing alone time and boundaries, and cautioning that in-laws can strain marriages through boundary issues, loyalty dilemmas, cultural or generational differences, and communication breakdowns, while recommending open communication, setting limits, and practicing empathy to manage in-law relationships.

A 25-Step Shower Routine? Experts Say That Can Do More Harm Than Good. (Brisbane Times (AUS))

The (7/10) Experts caution against elaborate 25-step shower routines popularized on social media, suggesting they may damage skin and waste resources, with Lisa O. Akintilo, MD, assistant professor, the Ronald O. Perelman Department of Dermatology, saying, “It’s nice to hear about skincare routines that do involve both cleansing and also providing hydration,” while dermatologists recommend simple practices like using lukewarm water, fragrance-free cleansers, and avoiding excessive exfoliation to maintain skin health and environmental responsibility.

Psychologist Explains True Reality As Ozempic Users Report Sex Drive Side Effect Of The Drug. (LADBible (UK))

(7/13) Rachel L. Goldman, PhD, clinical assistant professor, Department of Psychiatry, discussed with purewow how Ozempic can affect sex drive, explaining that GLP-1s impact the brain’s reward center, potentially leading to reduced interest in sex, though she has observed both increased and decreased libidos among her patients; Novo Nordisk, the manufacturer, emphasized that Ozempic should be prescribed by healthcare professionals for Type-2 diabetes, and they continue to monitor safety data and advise patients to report side effects.

News from ���ϸ����� Langone Health—Long Island

19 Academic Health Systems Acquiring Hospitals. (Becker's Hospital Review)

(7/11) ���ϸ����� Langone Health acquired Long Island Community Hospital in March 2025, marking its seventh inpatient facility now named ���ϸ����� Langone Hospital-Suffolk.